909854-04-2

Basic information

• Product Name: Silane, [(3,5-diethoxy-4-fluorophenyl)methoxy](1,1-dimethylethyl)dimethyl-
• CAS NO: 909854-04-2
• Molecular Formula: C17H29FO3Si
• Molecular Weight: 328.499
• Mol File: 909854-04-2.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Silane, [(3,5-diethoxy-4-fluorophenyl)methoxy](1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, [(3,5-diethoxy-4-fluorophenyl)methoxy](1,1-dimethylethyl)dimethyl-(909854-04-2)
• EPA Substance Registry System: Silane, [(3,5-diethoxy-4-fluorophenyl)methoxy](1,1-dimethylethyl)dimethyl-(909854-04-2)

Safety Data

• Hazardous Substances Data: 909854-04-2(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 113984-78-4 2-(tert-butyl-dimethyl-silanyloxy)-4-(tert-butyl-dimethyl-silanyloxymethyl)-1-fluoro-benzene 
• 113984-77-3 1-(tert-butyldimethylsiloxymethyl)-4-fluoro-3-hydroxybenzene 
• 113984-76-2 1-(tert-butyldimethylsilyloxymethyl)-4-fluorobenzene 
• 459-56-3 4-fluorobenzylic alcohol 
• 74-96-4 ethyl bromide 
• 113984-79-5 3-(tert-butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-4-fluoro-5-hydroxybenzene 

Downstream Products

• 909854-03-1 3,5-Diethoxy-4-fluoro-benzaldehyde 
• 909854-05-3 (3,5-diethoxy-4-fluoro-phenyl)-methanol 

Relevant articles and documents

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES

This invention relates to 4,4-disubstituted piperidine derivatives of the formula (I) wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmac

PYRIMIDINE AND QUINAZOLINE DERIVATIVES

This invention is concerned with compounds of the formula ( l ) wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES

This invention relates to compounds of the formula wherein A, R1 to R3 are as defined in the specification and G is benzoimidazole, quinoxaline, benzotriazole, dihydro-imidazo[4,5-c]pyridine and dihydro-isoindolone group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.